Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2020-11-12 06:00:42
Reporting Period:
Accepted Time:
2020-11-12 06:00:42
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1610618 Cidara Therapeutics Inc. CDTX () 4
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1478831 Jeffrey Stein 6310 Nancy Ridge Drive
Suite 101
San Diego CA 92121
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-10 50,000 $2.00 347,878 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 257,902 Indirect by trust
Common Stock 15,709 Indirect by son
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.99to $2.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range setforth above.
  2. Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2020.